HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Comella Selected Research

Drug Therapy (Chemotherapy)

8/2005A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study.
9/2002Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.
2/2002Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.
10/2001[Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level].
2/2001A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
7/2000Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.
4/2000Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group.
3/2000Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
3/2000Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.
2/2000Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Comella Research Topics

Disease

10Neoplasms (Cancer)
08/2005 - 02/2000
9Breast Neoplasms (Breast Cancer)
09/2011 - 03/2000
9Colorectal Neoplasms (Colorectal Cancer)
12/2002 - 04/2000
7Neutropenia
12/2002 - 03/2000
4Thrombocytopenia (Thrombopenia)
09/2011 - 03/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2001 - 02/2000
3Adenocarcinoma
07/2014 - 12/2003
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2003 - 03/2000
2Stomach Neoplasms (Stomach Cancer)
07/2014 - 02/2001
2Nausea
09/2011 - 03/2000
2Pain (Aches)
09/2011 - 03/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2004 - 12/2003
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2001 - 02/2000
2Squamous Cell Carcinoma of Head and Neck
02/2001 - 05/2000
1Vomiting
09/2011
1Neoplasm Metastasis (Metastasis)
04/2010
1Endometrial Neoplasms (Endometrial Cancer)
10/2003
1Asthenia
03/2003
1Exanthema (Rash)
03/2003
1Microsatellite Instability
09/2002
1Carcinoma (Carcinomatosis)
09/2002
1Anemia
10/2001
1Rectal Neoplasms (Rectal Cancer)
07/2001
1Fatigue
02/2001
1Diarrhea
01/2001
1Melanoma (Melanoma, Malignant)
12/2000
1Hemorrhage
03/2000
1Febrile Neutropenia
03/2000
1Alopecia (Baldness)
03/2000
1Disease Progression
02/2000
1Lung Neoplasms (Lung Cancer)
02/2000

Drug/Important Bio-Agent (IBA)

14Cisplatin (Platino)FDA LinkGeneric
07/2014 - 02/2000
10Fluorouracil (Carac)FDA LinkGeneric
07/2014 - 04/2000
9GemcitabineFDA Link
01/2005 - 02/2000
8Leucovorin (Folinic Acid)FDA Link
07/2014 - 04/2000
7Paclitaxel (Taxol)FDA LinkGeneric
04/2010 - 03/2000
6Docetaxel (Taxotere)FDA Link
07/2014 - 03/2000
6Irinotecan (Camptosar)FDA LinkGeneric
07/2014 - 04/2000
6Epirubicin (Ellence)FDA LinkGeneric
04/2010 - 07/2000
6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2009 - 07/2000
6raltitrexed (D 1694)IBA
06/2002 - 04/2000
5Vinorelbine (Navelbine)FDA LinkGeneric
12/2001 - 02/2000
4Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2002 - 04/2000
3AcidsIBA
07/2001 - 05/2000
2liposomal doxorubicin (Doxil)FDA Link
09/2011 - 03/2000
21-(9-fluorenyl)ethyl chloroformateIBA
12/2004 - 12/2003
2Methotrexate (Mexate)FDA LinkGeneric
03/2003 - 10/2000
2AnthracyclinesIBA
06/2001 - 03/2000
1Aligeron (AS 2)IBA
07/2014
1Alkaline PhosphataseIBA
09/2011
1Trastuzumab (Herceptin)FDA Link
09/2011
1Biomarkers (Surrogate Marker)IBA
04/2010
1Carboplatin (JM8)FDA LinkGeneric
12/2003
1Calcibiotic Root Canal SealerIBA
10/2003
1olivacineIBA
03/2003
1NSC 659687IBA
03/2003
1ParaffinIBA
09/2002
1DNA (Deoxyribonucleic Acid)IBA
09/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2001
1taxaneIBA
06/2001
1Taxoids (Taxanes)IBA
06/2001
1Topotecan (Hycamtin)FDA LinkGeneric
05/2001
1Glutathione (Reduced Glutathione)IBA
02/2001
1Filgrastim (Neupogen)FDA Link
02/2001
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2001
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2001
1cyclo(Arg-Pro) (CI 4)IBA
01/2001
1Interferon-alpha (Interferon Alfa)IBA
12/2000
1fotemustine (Muphoran)IBA
12/2000
1FM 100 (FM100)IBA
12/2000
1Dacarbazine (DIC)FDA LinkGeneric
12/2000
1LevoleucovorinFDA Link
10/2000
1Drug CarriersIBA
03/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2000
1Liposomes (Liposome)IBA
03/2000
1Pharmaceutical PreparationsIBA
03/2000
1ambamustineIBA
02/2000
1Alkylating AgentsIBA
02/2000

Therapy/Procedure

10Drug Therapy (Chemotherapy)
08/2005 - 02/2000
4Therapeutics
08/2005 - 07/2001
2Radiotherapy
09/2002 - 07/2001
1PET regimen
10/2006
1Chemoradiotherapy
07/2003
1Palliative Care (Palliative Therapy)
12/2002
1Adjuvant Chemotherapy
09/2002
1Adjuvant Radiotherapy
09/2002
1Salvage Therapy
06/2002
1Blood Transfusion (Blood Transfusions)
10/2001